Accenture Backs Iridius to Advance Compliance-Driven AI Adoption in Life Sciences

Strategic partnership embeds compliance, traceability, and auditability into AI to accelerate innovation across the life sciences value chain Accenture, listed on NYSE: ACN, has announced a strategic investment in Iridius through its venture arm, Accenture Ventures. The move underscores Accenture’s…









